Trial Profile
A study of NAL-3210 for the treatment of Onychomycosis
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2016
Price :
$35
*
At a glance
- Drugs NAL 3210 (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- 17 Sep 2016 New trial record